← Back to Search

Mental Health Support for Emergency Responders

N/A

Waitlist Available

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants will be emergency responders defined as fire fighters, law enforcement officers, emergency medical service personnel, emergency room medical providers (physicians, nurses, physician assistants), emergency dispatchers, and emergency response trainees who have completed training experiences in which they encountered emergencies

Participants will be age 18 or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the phq-9 will be administered at baseline and follow-up (7 months post-baseline).

Awards & highlights

Study Summary

This trial will help emergency responders protect their mental health despite occupational hazards.

Who is the study for?

This trial is for emergency responders over 18 in Pennsylvania, including firefighters, law enforcement officers, EMS personnel, ER medical providers, dispatchers, and trainees with emergency experience. It's not for those with psychotic/bipolar disorders or severe brain impairment.Check my eligibility

What is being tested?

The Pitt Center aims to improve mental health of emergency responders through the Unified Protocol treatment. The study will test its effectiveness and feasibility while training students in mental healthcare delivery.See study design

What are the potential side effects?

Since this intervention involves psychological therapy rather than medication, typical side effects associated with drugs are not expected. However, participants may experience emotional discomfort addressing their mental health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an emergency responder or have completed training in emergency response.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the phq-9 will be administered at baseline and follow-up (7 months post-baseline).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the phq-9 will be administered at baseline and follow-up (7 months post-baseline).

This trial's timeline: 3 weeks for screening, Varies for treatment, and the phq-9 will be administered at baseline and follow-up (7 months post-baseline). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline to follow-up in alcohol misuse severity measured using the Alcohol Use Disorders Identification Test (AUDIT)

Change from baseline to follow-up in anxiety symptom severity measured using the Generalized Anxiety Disorder-7 (GAD-7)

Change from baseline to follow-up in depressive symptoms measured using the Patient Health Questionnaire-9 (PHQ-9)

+5 more

Secondary outcome measures

Change from baseline to follow-up in functional impairment measured using the Work and Social Adjustment Scale (WSAS)

Change from baseline to follow-up in quality of life measured using the World Health Organization Quality of Life (WHOQOL-BREF).

Change from baseline to post-treatment in functional impairment measured using the Work and Social Adjustment Scale (WSAS)

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Transdiagnostic cognitive behavioral therapyExperimental Treatment1 Intervention

Transdiagnostic cognitive behavioral therapy

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Unified Protocol for Transdiagnostic Treatment of Emotional Disorders

2020

N/A

~110

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor

1,719 Previous Clinical Trials

16,342,305 Total Patients Enrolled

Eric C Meyer, PhDStudy DirectorUniversity of Pittsburgh

Media Library

Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Clinical Trial Eligibility Overview. Trial Name: NCT05357586 — N/A

Post-Traumatic Stress Disorder Research Study Groups: Transdiagnostic cognitive behavioral therapy

Post-Traumatic Stress Disorder Clinical Trial 2023: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Highlights & Side Effects. Trial Name: NCT05357586 — N/A

Unified Protocol for Transdiagnostic Treatment of Emotional Disorders 2023 Treatment Timeline for Medical Study. Trial Name: NCT05357586 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of this trial in terms of participant numbers?

"Affirmative. Clinicaltrials.gov records that recruitment for this trial began on March 29th, 2022 and was last updated April 26th, 2022. The study is searching for 60 volunteers from 1 medical centre."

Answered by AI

What are the major aims of this research endeavor?

"The core objective of the trial is to evaluate changes in anxiety symptom severity across a 7-month period, as measured by the PHQ-9. Secondary measures include assessing alterations in quality of life (WHOQOL-BREF) and functional impairment (WSAS)."

Answered by AI

Does this research endeavor presently admit new participants?

"Affirmative. The clinicaltrials.gov page illustrates that the study, first listed on March 29th 2022 is currently accepting applications. There are 60 spots available at a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Pitt Center for Emergency Responder Wellness

Eric Meyer 2022. "The Pitt Center for Emergency Responder Wellness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05357586.